Vaccination with peptides from MHC class II beta chain hypervariable region causes allele-specific suppression of EAE

Journal of Neuroimmunology

Volumn 67, Issue 2, 1996, Pages 119-124

  Bright, John J ^a   Topham, David J ^b   Nag, Bishwajit ^c   Lodge, Patricia A ^a   Sriram, Subramaniam ^a  

^a Vanderbilt Stallworth Rehabilitation Hospital   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Experimental allergic encephalomyelitis; MHC antigens; Multiple sclerosis; Vaccination

Indexed keywords

IA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; SYNTHETIC PEPTIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

EID: 0030200136     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00057-4     Document Type: Article

References (26)

1. Acha-Orbea, H., Mitchell, D.J., Timmerman, L., Tausch, G.S., Waldor, M.K., Zamvil, S.S., McDevitt, H.O. and Steinman, L.S. (1988) Limited Heterogeneity of T cell receptors from lymphocytes mediating EAE alows specific immune intervention. Cell 54, 263-273.
2. Adelman, N.E., Wadling D.L. and McDevitt, H.O. (1983) Treatment of (NZB × NZW)F1 disease with anti I-A monoclonal antibodies. J. Exp. Med. 158, 1350-1357.
3. Ben-Nun A., Yossifi, S. and Lehman, D. (1993) Protection against autoimmune disease by bacterial agents; PPD and pertussis toxin are protective in EAE. Eur. J. Immunol. 23, 689-696.
4. Brostoff, S.W. and White, T. M. (1986) Treatment of EAE in rats with monoclonal antibodies. J. Neuroimmunol. 13, 233-242.
5. Campbell, R.D. and Milner, C.M. (1993) MHC genes and autoimmunity. Curr. Opin. Immunol. 5, 887-893.
6. Fallis, R.J., Powers, M.L., Sy, M.-S. and Weiner H.L. (1987) Adoptive transfer of murine murine autoimmune encephalomyelitis: analysis of basic protein reactive cells in lymphoid organs and nervous system of donor and recipient animals. J. Neuroimmunol. 14, 205-215.
7. Germain, R. (1994) MHC dependent antigen processing and peptide presentation. Cell 76, 287-300.
8. Kruisbeek, A.M., Bridges, S., Carmen, J., Longo, D.L., Mond, J.J. (1985) In vivo treatment of neonatal mice with anti I-A antisera interferes with the development of splenic antigen presenting cells function concomitant with modulation of cells surface I-A and I-E antigens, J. Immunol. 134, 3605-3611.
9. Lider, O., Reshef, T., Beraud, E., Ben-Nun, A. and Cohen, I.R. (1987) Anti-idiotypic network induced by T-cell vaccination against EAE. Science 239, 181-183.
10. Mcfarlin, D.E. and Mcfarland, H.F. (1982) Multiple Sclerosis. N. Eng. J. Med. 307, 1183-1188.
11. Morris, S.C., Lees, A., Inman, J. and Finkelman, F.D. (1992) Role of antigen-specific T cell help in the generation of in vivo antibody response to conalbumin. 1. Antigen-specific T cell help is required to generate a polyclonal IdG1 response in anti IgD antibody injected mice. J. Immunol. 149, 3836-3844.
12. Nepom, G.T. and Erlich, H. (1991) MHC class II molecules and autoimmunity, Ann. Rev Immunol. 9, 493-525.
13. Ota, K., Matsui, M., Milford, E.L., Mackin, G.A., Weiner, H.L. and Hafler, D.A. (1990) T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346, 183-185.
14. Raine, C. (1984) Analysis of autoimmune demyelination: its impact on MS. Lab. Invest. 50, 604-623.
15. Rosenbaum, J.T., Adelman, N.E. and McDevitt, H.O. (1981) In vivo effects of antibodies to immune response gene products: Haplotype specific suppression of humoral immune response with a monoclonal anti IA antibody. J. Exp. Med. 154, 1694-1703.
16. Sprent, J.(1980) Effects of blocking helper T cell activity in vivo with anti IA antibodies: Possible role of I-I-A/I-E hybrid molecules as restriction elements. J. Exp. Med. 152, 996-1003.
17. Sriram, S. and Steinman, L.S. (1983) Anti IA antibody suppresses active EAE: treatment model for diseases linked to IR genes. J. Exp. Med. 158, 1362-1368.
18. Sriram, S., Topham, D.J. and Carroll, L. (1987) Haplotype-Specific suppression of experimental allergic encephalomyelitis with anti-IA antibodies. J. Immunol. 139, 1485-1489.
19. Steinman, L.S. (1991) The development of rational strategies for selective immunotherapy against autoimmune disease. Adv. Immunol. 49, 357-379.
20. Tiwari, J. and Terasaki, P. (1985) GLA and disease associations. Springer Verlag, New York.
21. Todd, J.A., Acha-Orbea, H. and Bell, H.(1988) A molecular basis for MHC class II associated autoimmunity. Science 240, 1003-1009.
22. Topham, D.J., Nag, B., Arimilli, S., and Sriram, S. (1994) A synthetic peptide from the third hypervariable region of major histocompatibility complex class II beta chain as a vaccine for treatment of experimental allergic encephalitis. Proc. Natl. Acad. Sci. 91, 8005-8009.
23. Usuku, K., Joshi, N. and Hauser, S.L. (1992) T-cell receptors: Germline polymorphisms and pattern usage in demyelinating diseases. Critical Reviews in Immunology 11, 381-388.
24. Vandenbark, A.A., Hashim, G. and Offner, H. (1989) Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341, 541-544.
25. Zaller, D.M., Osman, G., Kanagawa, O., and Hood, L. (1990) Prevention and treatment of murine EAE with the T cell receptor V β specific antibodies. J. Exp. Med. 171, 1943-1950.
26. Zamvil, S.S. and Steinman, L. (1990) The T lymphocyte in EAE. Ann. Rev. Immunol. 8, 579-6210.